UnitedHealth Group Incorporated (NYSE:UNH) had its target price upped by Citigroup Inc. from $195.00 to $213.00 in a research report report published on Wednesday morning. They currently have a buy rating on the healthcare conglomerate’s stock.
Other research analysts also recently issued reports about the company. Deutsche Bank AG began coverage on UnitedHealth Group in a report on Wednesday, April 5th. They set a buy rating and a $183.00 price objective on the stock. UBS AG restated a buy rating and set a $194.00 price objective (up from $193.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Cantor Fitzgerald restated an overweight rating and set a $205.00 price objective (up from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein restated an outperform rating and set a $190.00 price objective on shares of UnitedHealth Group in a report on Monday, July 10th. Finally, Credit Suisse Group restated an outperform rating and set a $200.00 price objective (up from $195.00) on shares of UnitedHealth Group in a report on Thursday, July 13th. One analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company currently has a consensus rating of Buy and an average price target of $198.07.
UnitedHealth Group (NYSE:UNH) opened at 191.78 on Wednesday. The stock’s 50 day moving average price is $184.43 and its 200 day moving average price is $171.28. The stock has a market capitalization of $184.81 billion, a PE ratio of 24.55 and a beta of 0.64. UnitedHealth Group has a 1-year low of $132.39 and a 1-year high of $193.00.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping the consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period last year, the business posted $1.96 EPS. On average, equities research analysts predict that UnitedHealth Group will post $9.86 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Shareholders of record on Monday, June 19th were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, June 15th. This represents a $3.00 dividend on an annualized basis and a yield of 1.56%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.63. UnitedHealth Group’s payout ratio is currently 35.13%.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders own 0.89% of the company’s stock.
A number of hedge funds have recently modified their holdings of the company. Quest Investment Management Inc. OR boosted its stake in shares of UnitedHealth Group by 2.1% in the fourth quarter. Quest Investment Management Inc. OR now owns 103,313 shares of the healthcare conglomerate’s stock worth $16,534,000 after buying an additional 2,102 shares in the last quarter. Glassman Wealth Services boosted its stake in shares of UnitedHealth Group by 24.9% in the fourth quarter. Glassman Wealth Services now owns 947 shares of the healthcare conglomerate’s stock worth $152,000 after buying an additional 189 shares in the last quarter. Moloney Securities Asset Management LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $1,024,000. Polaris Capital Management LLC boosted its stake in shares of UnitedHealth Group by 23.5% in the fourth quarter. Polaris Capital Management LLC now owns 209,780 shares of the healthcare conglomerate’s stock worth $33,573,000 after buying an additional 39,884 shares in the last quarter. Finally, Intellectus Partners LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $111,000. 86.21% of the stock is owned by institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
